Keyword search

Description: Number of deaths caused by diseases of the nervous system, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the eye and adnexa, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the circulatory system, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the digestive system, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the skin and subcutaneous tissue, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the musculoskeletal system and connective tissue, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the genitourinary system, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by certain conditions originating in the perinatal period, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by diseases of the ear and mastoid process, by age group and sex, 2000 to most recent year.

Description: Long term symptoms were defined as having COVID-19 symptoms at least 3 months after a self-reported positive test or suspected SARS-CoV-2 infection. Results on the status of long-term symptoms only included respondents for whom a period of three months separated their self-reported date of infection and the date they completed the questionnaire.

Description: This survey provides new evidence about those who indicated on their electronic questionnaire a positive test result with either a positive polymerase chain reaction (PCR) test or a rapid antigen test (RAT), as well as those who suspected that they had an infection. These results are based on the individual's self-reported first positive test result or first suspected infection and does not account for multiple infections.

Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty, cause of death or injury and reason for non-evacuation, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.

Description: Incident-based fire statistics, by type of casualty, age group of casualty, status of casualty and type of structure, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.

Description: Incident-based fire statistics, by performance of smoke alarm device, residential fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.

Description: Incident-based fire statistics, by performance of sprinkler system, structural fires and type of incident and casualty, Canada, Nova Scotia, New Brunswick, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon, Canadian Armed Forces, 2005 to 2021.

Description: This public use microdata file (PUMF) provides researchers access to data on the distribution of SARS-CoV-2 lineages detected in the Canadian provinces between May and September 2022. Samples were collected as part of the Canadian COVID-19 Antibody and Health Survey (CCAHS), Cycle 2. The PUMF file consists of a subset of participants of the CCAHS who submitted a positive PCR saliva sample over the course of the collection of the survey. The PUMF contains select demographic information including sex at birth, age group, province and the week of collection. The file also contains SARS-CoV-2 whole genome sequences and its associated data.

Description:

Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

Description: This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, willingness to receive vaccine and the number of vaccinated and unvaccinated persons. Estimates are based on preliminary bi-annual data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by region of residence and other demographic characteristics.

Description: Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.

Description: To better understand the interplay between adiposity and metabolic health, joint phenotypes have been used to categorize people as being metabolically healthy or metabolically unhealthy while having a body mass index indicative of obesity, overweight, or normal weight. This study examines the prevalence of these phenotypes in adults, the factors associated with them, and their relationship with adverse health outcomes.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: This fact sheet provides an overview of proportions of Canadians who have undergone tests commonly used for early detection of colorectal, cervical and breast cancer among people living in the ten provinces. It also examines differences by various groups, such as by sex, age, province, area type, racialized group, immigrant status, Indigenous group and disability status.

Description: The OncoSim-Breast model, developed by the Canadian Partnership Against Cancer and Statistics Canada, represents breast cancer-related events in the Canadian female population. This study aims to compare OncoSim-Breast microsimulation modelling results with recent results from the United States’ National Cancer Institute’s Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. The primary focus is on the impact of extending breast cancer screening to women aged 40 to 49.

Description: Multimorbidity is the co-occurrence of two or more chronic diseases, and is a significant challenge for health care systems worldwide. There are limited data, particularly in a Canadian context, on multimorbidity prevalence and incidence. This study analyzed trends in the prevalence and incidence of multimorbidity and complex multimorbidity (five or more conditions) by sex, age, and neighbourhood income quintile in British Columbia. This study also identified the most prevalent disease combinations.

Description: The prevalence of Canadian adults with obesity has been steadily increasing over the past four decades. Nine percent of Canadian adults had obesity in 1981, 27.2% had obesity in 2018 and the most recent estimates from 2022 indicate that 30% of Canadian adults have obesity. The purpose of this study is to describe the obesity change pattern among Canadian adults aged 28 to 79 years and to examine associations between obesity history and health outcomes.

Description: After six cycles of using the BpTRU (BT) BPM-300 blood pressure (BP) monitor, the Canadian Health Measures Survey (CHMS) introduced the OMRON (OM) IntelliSense HEM-907XL BP monitor in Cycle 7. This study assesses differences between BP values measured by both devices in children and youth aged 6 to 17 years and whether equations could be developed to compare BP measurements taken using the two devices.

Description: Managing breast cancer involves a range of health care settings and has considerable implications on health care resources. While studies have looked at breast cancer costs in Canada by subtype and stage, there is a gap in understanding breast cancer costs related to phase of care and disease stage. This study assessed health care system costs and resource utilization for adult women with breast cancer in Ontario, Canada. The goal was to update costs by stage, age, and phase of care from a health care system perspective.

Description: Utilizing data from the 2022 Canadian Survey on Disability, this infographic highlights the trends and experiences of persons with pain-related disabilities. This release is part of a series of infographics that focus on specific disability types.

Description: In Cycle 7 (2022), the Canadian Health Measures Survey (CHMS) introduced the OMRON (OM) IntelliSense HEM-907XL blood pressure (BP) monitor after using the BpTRU (BT) BPM-300 BP monitor for six cycles. This study assess differences between adult BP values measured by both devices and whether equations could be developed to compare BP measurements taken using the two devices.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

Description:

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

Description:

This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.